Skip to main content
. Author manuscript; available in PMC: 2016 Nov 14.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 May 24;20(7):1453–1462. doi: 10.1158/1055-9965.EPI-11-0042

Table 1. Details of the lung cancer patients and controls studied.

Phase 1 Phase 2¥
Cases Control subjects Cases Control subjects
Number (Male; %) 1,978 (1,203, 60%) 5,999 (-,-) 2,484 (1,690, 68%) 3,036 (1,497, 49%)
Mean age (SD) years 57 (6) - 72 (7) 61 (11)
Family history of lung cancer* 287 (15%) - 348 (14%) -
Lung cancer histology -
NSCLC 1,441 (73%) - 1,938 (78%) -
Adenocarcinoma 472 (24%) - 439 (18%) -
Squamous 620 (31%) - 1,072 (43%) -
Other 349 (18%) - 427 (17%) -
SCLC 535 (27%) - 512 (21%) -
Other 2 (< 1%) - 34 (1%) -
Smoking Status
Former smokers 1,188 (60%) - 1,726 (69%) 585 (19%)
Ever Smokers 680 (34%) - 549 (22%) 341 (11%)
Never smokers 110 (6%) - 132 (5%) 553 (18%)
Unknown 0 (0%) - 77 (3%) 1,557 (51%)
Mean CPD (SD) 23 (12) - 22 (13) 18 (11)
*

defined as having at least one first-degree relative affected with lung cancer

¥

Chi-square test is used in the test of gender difference between cases and controls; and student-t test is used for test of age and mean CPD differences; P-values are all <0.05.

SD, standard deviation

NSCLC, non-small cell lung cancer

SCLC, small cell lung cancer

CPD, cigarettes per day